Laboratory for Pharmacotechnology and Biopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium.
Antiviral Res. 2011 Aug;91(2):217-23. doi: 10.1016/j.antiviral.2011.06.001. Epub 2011 Jun 6.
In the search for a successful HIV microbicide, many poorly water-soluble antiviral agents are currently being investigated. Unfortunately, solubility and precipitation issues may limit intravaginal concentrations and thus availability of these agents upon application of an aqueous gel formulation. In the present study, we evaluated the in vitro precipitation behavior of the HIV protease inhibitor saquinavir in vaginal and seminal fluid simulants (VFS and SFS). Despite its limited solubility, the mesylate salt of saquinavir enables formulation of sufficiently high concentrations (2.5 mM, i.e. ca. 10(5)-fold in vitro IC(50) values) in a standard aqueous vehicle. While saquinavir stays in solution upon dilution with VFS, SFS induces precipitation of saquinavir, resulting in a 5-fold reduced availability and antiviral potency. Inclusion of the solubilizing excipients polyethylene glycol 1000 (12%) and hydroxypropyl-β-cyclodextrin (2.5%) was required to avoid saquinavir precipitation in SFS and to restore the antiviral potency of the formulation. This study illustrates the importance of identifying solubility and precipitation issues of microbicide candidates in biorelevant media and provides a simple in vitro procedure to implement this evaluation in early microbicide development.
在寻找成功的 HIV 杀微生物剂的过程中,目前正在研究许多水溶性较差的抗病毒药物。不幸的是,溶解度和沉淀问题可能会限制阴道内浓度,从而限制水凝胶制剂应用时这些药物的可用性。在本研究中,我们评估了 HIV 蛋白酶抑制剂沙奎那韦在阴道和精液模拟液(VFS 和 SFS)中的体外沉淀行为。尽管沙奎那韦的水溶性有限,但它的甲磺酸盐能够在标准水性载体中形成足够高的浓度(2.5mM,即体外 IC50 值约为 105 倍)。虽然沙奎那韦在与 VFS 稀释时仍保持溶解状态,但 SFS 会诱导沙奎那韦沉淀,导致可用性降低 5 倍,抗病毒效力降低。需要加入增溶剂聚乙二醇 1000(12%)和羟丙基-β-环糊精(2.5%)以避免 SFS 中沙奎那韦沉淀,并恢复制剂的抗病毒效力。本研究说明了在生物相关介质中识别杀微生物候选物的溶解度和沉淀问题的重要性,并提供了一种简单的体外程序,以在早期杀微生物剂开发中实施这种评估。